Kezdőlap › Akut mieloid leukémia › Észak-Karolina › Durham
Akut mieloid leukémia klinikai vizsgálatok: Durham, NC
33 Akut mieloid leukémia vizsgálat keres résztvevőket Durham és környéke (kb. 30 mérföldes körzetben) helyszínein. Nyissa meg a vizsgálatot, hogy lássa, ki csatlakozhat, és hogyan léphet kapcsolatba a csapattal.
Hivatalos vizsgálati szöveg (angol)
Vizsgálatra keres résztvevőket? Emelje ki az oldal tetején — $99 / 30 nap →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Toborzás folyamatban2. fázis
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mérföldre
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Toborzás folyamatbanMegfigyeléses tanulmányEgészséges önkéntesek is jelentkezhetnek
- Durham VA Medical Center, Durham
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Toborzás folyamatban2. fázis
- Duke University Medical Center, Durham
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Toborzás folyamatban2. fázis
- Duke University Medical Center, Durham
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Toborzás folyamatban2. fázis
- Duke University Medical Center, Durham
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Toborzás folyamatban2. fázis
- Duke University Medical Center, Durham
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Toborzás folyamatban3. fázis
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mérföldre
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Toborzás folyamatban1/2. fázis
- Duke University Medical Center, Durham
Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
Toborzás folyamatban1. fázis
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mérföldre
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Toborzás folyamatban1/2. fázis
- UNC School of Medicine, Division of Hematology, Chapel Hill · 10 mérföldre
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
Toborzás folyamatban3. fázis
- US-Chapel Hill-UNCNORTHCAROLINA, Chapel Hill · 10 mérföldre
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Toborzás folyamatban1/2. fázis
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mérföldre
A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
Toborzás folyamatban1. fázis
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mérföldre
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Toborzás folyamatban3. fázis
- Duke University Medical Center, Durham
- University of North Carolina, Chapel Hill, Chapel Hill · 10 mérföldre
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
Toborzás folyamatban1. fázis
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mérföldre
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
Toborzás folyamatban1/2. fázis
- Research Site, Durham
- Research Site, Chapel Hill · 10 mérföldre
Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents
Toborzás folyamatban2. fázis
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mérföldre
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Toborzás folyamatbanMegfigyeléses tanulmány
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mérföldre
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
Toborzás folyamatban
- University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mérföldre
Registry of Older Patients With Cancer
Toborzás folyamatbanMegfigyeléses tanulmány
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mérföldre
IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study)
Toborzás folyamatban2. fázis
- UNC Hospitals, University of North Carolina at Chapel Hill, Chapel Hill · 10 mérföldre
A Study of Revumenib and Mezigdomide in People With Leukemia
Toborzás folyamatban1/2. fázis
- University of North Carolina (Data Collection Only), Chapel Hill · 10 mérföldre
SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation
Toborzás folyamatban1. fázis
- UNC Hospitals, University of North Carolina at Chapel Hill, Chapel Hill · 10 mérföldre
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Toborzás folyamatban1. fázis
- University of North Carolina, Chapel Hill · 10 mérföldre
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Toborzás folyamatban2/3. fázis
- Duke University, Durham
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Toborzás folyamatban1/2. fázis
- Duke University, Durham
- UNC Hospital, Chapel Hill · 10 mérföldre
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Toborzás folyamatban2. fázis
- University of North Carolina, Chapel Hill · 10 mérföldre
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Toborzás folyamatban1. fázis
- Duke Blood Cancer Center, Durham
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Toborzás folyamatban1. fázis
- Duke Cancer Center, Durham
Novel Digital Application for Patients With Acute Leukemia
Toborzás folyamatban
- Duke University, Durham
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Toborzás folyamatbanMegfigyeléses tanulmány
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mérföldre
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Toborzás folyamatban1/2. fázis
- Duke University Medical Center, Durham
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
Toborzás folyamatbanEgészséges önkéntesek is jelentkezhetnek
- Duke University, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mérföldre
Akut mieloid leukémia vizsgálatok más városokban
- Houston, TX85 tanulmány
- New York City, NY51 tanulmány
- Boston, MA44 tanulmány
- Seattle, WA41 tanulmány
- Baldwin Park, CA40 tanulmány
- Columbus, OH35 tanulmány
- Philadelphia, PA34 tanulmány
- Atlanta, GA31 tanulmány
- Tampa, FL29 tanulmány
- Chicago, IL26 tanulmány
- Portland, OR25 tanulmány
- Washington, DC24 tanulmány
Egyéb vizsgálatok: Durham
- Mellrák64 tanulmány
- Rák (minden típus)58 tanulmány
- Nem kis sejtes tüdőrák39 tanulmány
- Multiplex mielóma37 tanulmány
- Áttétes rák33 tanulmány
- Prosztatarák32 tanulmány
- Tüdőrák32 tanulmány
- Kolorektális rák28 tanulmány
- Petefészekrák27 tanulmány
- Krónikus limfocitás leukémia27 tanulmány
- Szívelégtelenség26 tanulmány
- Hasnyálmirigyrák24 tanulmány
Forrás: ClinicalTrials.gov, adatok lekérve: 2026. okt. 6.. Minden vizsgálat saját alkalmassági feltételeket határoz meg; a döntést a vizsgálati csapat hozza meg.